Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant
Beta (B.1.351)–variant coronavirus disease 2019 (COVID-19) disease was investigated in Qatar. Compared with the Alpha (B.1.1.7) variant, odds (95% confidence interval) of progressing to severe disease, critical disease, and COVID-19–related death were 1.24-fold (1.11–1.39), 1.49-fold (1.13–1.97), an...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402694/ https://www.ncbi.nlm.nih.gov/pubmed/34657152 http://dx.doi.org/10.1093/cid/ciab909 |
_version_ | 1784773217234190336 |
---|---|
author | Abu-Raddad, Laith J Chemaitelly, Hiam Ayoub, Houssein H Yassine, Hadi M Benslimane, Fatiha M Al Khatib, Hebah A Tang, Patrick Hasan, Mohammad R Coyle, Peter AlMukdad, Sawsan Al Kanaani, Zaina Al Kuwari, Einas Jeremijenko, Andrew Kaleeckal, Anvar Hassan Latif, Ali Nizar Shaik, Riyazuddin Mohammad Abdul Rahim, Hanan F Nasrallah, Gheyath K Al Kuwari, Mohamed Ghaith Butt, Adeel A Al Romaihi, Hamad Eid Al-Thani, Mohamed H Al Khal, Abdullatif Bertollini, Roberto |
author_facet | Abu-Raddad, Laith J Chemaitelly, Hiam Ayoub, Houssein H Yassine, Hadi M Benslimane, Fatiha M Al Khatib, Hebah A Tang, Patrick Hasan, Mohammad R Coyle, Peter AlMukdad, Sawsan Al Kanaani, Zaina Al Kuwari, Einas Jeremijenko, Andrew Kaleeckal, Anvar Hassan Latif, Ali Nizar Shaik, Riyazuddin Mohammad Abdul Rahim, Hanan F Nasrallah, Gheyath K Al Kuwari, Mohamed Ghaith Butt, Adeel A Al Romaihi, Hamad Eid Al-Thani, Mohamed H Al Khal, Abdullatif Bertollini, Roberto |
author_sort | Abu-Raddad, Laith J |
collection | PubMed |
description | Beta (B.1.351)–variant coronavirus disease 2019 (COVID-19) disease was investigated in Qatar. Compared with the Alpha (B.1.1.7) variant, odds (95% confidence interval) of progressing to severe disease, critical disease, and COVID-19–related death were 1.24-fold (1.11–1.39), 1.49-fold (1.13–1.97), and 1.57-fold (1.03–2.43) higher, respectively, for the Beta variant. |
format | Online Article Text |
id | pubmed-9402694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94026942022-08-25 Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant Abu-Raddad, Laith J Chemaitelly, Hiam Ayoub, Houssein H Yassine, Hadi M Benslimane, Fatiha M Al Khatib, Hebah A Tang, Patrick Hasan, Mohammad R Coyle, Peter AlMukdad, Sawsan Al Kanaani, Zaina Al Kuwari, Einas Jeremijenko, Andrew Kaleeckal, Anvar Hassan Latif, Ali Nizar Shaik, Riyazuddin Mohammad Abdul Rahim, Hanan F Nasrallah, Gheyath K Al Kuwari, Mohamed Ghaith Butt, Adeel A Al Romaihi, Hamad Eid Al-Thani, Mohamed H Al Khal, Abdullatif Bertollini, Roberto Clin Infect Dis Brief Report Beta (B.1.351)–variant coronavirus disease 2019 (COVID-19) disease was investigated in Qatar. Compared with the Alpha (B.1.1.7) variant, odds (95% confidence interval) of progressing to severe disease, critical disease, and COVID-19–related death were 1.24-fold (1.11–1.39), 1.49-fold (1.13–1.97), and 1.57-fold (1.03–2.43) higher, respectively, for the Beta variant. Oxford University Press 2021-10-17 /pmc/articles/PMC9402694/ /pubmed/34657152 http://dx.doi.org/10.1093/cid/ciab909 Text en © The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Brief Report Abu-Raddad, Laith J Chemaitelly, Hiam Ayoub, Houssein H Yassine, Hadi M Benslimane, Fatiha M Al Khatib, Hebah A Tang, Patrick Hasan, Mohammad R Coyle, Peter AlMukdad, Sawsan Al Kanaani, Zaina Al Kuwari, Einas Jeremijenko, Andrew Kaleeckal, Anvar Hassan Latif, Ali Nizar Shaik, Riyazuddin Mohammad Abdul Rahim, Hanan F Nasrallah, Gheyath K Al Kuwari, Mohamed Ghaith Butt, Adeel A Al Romaihi, Hamad Eid Al-Thani, Mohamed H Al Khal, Abdullatif Bertollini, Roberto Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant |
title | Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant |
title_full | Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant |
title_fullStr | Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant |
title_full_unstemmed | Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant |
title_short | Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant |
title_sort | severity, criticality, and fatality of the severe acute respiratory syndrome coronavirus 2 (sars-cov-2) beta variant |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402694/ https://www.ncbi.nlm.nih.gov/pubmed/34657152 http://dx.doi.org/10.1093/cid/ciab909 |
work_keys_str_mv | AT aburaddadlaithj severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT chemaitellyhiam severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT ayoubhousseinh severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT yassinehadim severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT benslimanefatiham severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT alkhatibhebaha severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT tangpatrick severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT hasanmohammadr severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT coylepeter severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT almukdadsawsan severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT alkanaanizaina severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT alkuwarieinas severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT jeremijenkoandrew severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT kaleeckalanvarhassan severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT latifalinizar severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT shaikriyazuddinmohammad severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT abdulrahimhananf severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT nasrallahgheyathk severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT alkuwarimohamedghaith severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT buttadeela severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT alromaihihamadeid severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT althanimohamedh severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT alkhalabdullatif severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant AT bertolliniroberto severitycriticalityandfatalityofthesevereacuterespiratorysyndromecoronavirus2sarscov2betavariant |